Furthermore, to our best knowledge the current findings propose for the first time that BDNF is a target gene of SFRP1 with putative suppressive characteristics in breast cancer, thus highlighting its clinical relevance in a completely different and novel way. This evidence concerns the gene SFRP1 and breast carcinoma.